Skip to main content
OpenTrials
Completed

NCT Number: NCT01060800

The Genetics of Chiari Type I Malformation

Duke University Medical Center is investigating the hereditary basis of Chiari type I malformations with or without syringomyelia (CM1/S). Our research is aimed at learning if CM1/S is indeed caused by factors inherited through the family and, if so, which genes are involved.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

Duke University Medical Center

Durham, North Carolina, 27710, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

The study is not currently enrolling new participants.

Treatment and study plan

Primary outcomes

  1. Genetic factors contributing to Chiari Type I malformation

    Time frame: end of study

    This study aims to identify genetic factors that contribute to or cause Chiari Type I malformation.

Sponsors and collaborators

Lead sponsor

Duke University

Other

Registry information

Official study title

The Genetics of Chiari Type I Malformation (CMI) With or Without Syringomyelia

Important dates

Study start
2009
Primary completion
2017
Study completion
2017
First posted
Feb 2, 2010
Registry last updated
Apr 2, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.